‘Transformative’ HIV PrEP shot slowly overcomes cost hurdles

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but ...
Metro Weekly

FDA Approves PrEP Drug Requiring Only Two Injections Per Year

The U.S. Food and Drug Administration has approved a highly effective HIV prevention drug that outperforms oral medications in stopping HIV transmission. Developed by Gilead Sciences, the drug ...
来自MSN

PrEP: The drug being used to eradicate new HIV diagnoses in Northern Ireland by 2030

Imagine living in a world where new cases of HIV are no longer a daily reality. That’s the ambitious but increasingly realistic goal for Northern Ireland by 2030. At the heart of this hope is PrEP, or ...
Yahoo

UK approves Gilead’s twice-yearly HIV PrEP drug

Add Yahoo as a preferred source to see more of our stories on Google. Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option for ...
NBC Bay Area

FDA approves powerful HIV drug that nearly eliminated spread in clinical trials

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
Seeking Alpha

Gilead granted EU nod for twice-yearly HIV PrEP therapy

Gilead Sciences (NASDAQ:GILD) announced on Tuesday that the European Commission granted marketing authorization for its antiviral therapy lenacapavir as a twice-yearly option for the prevention of HIV ...